Fundraising Fox
🦊/People
Sign in

Paulina Hill

Investor

Partner at Sanofi Ventures · Board director at Avilar Therapeutics · Board director at NextPoint Therapeutics

Cambridge, Massachusetts, United States

Find your path to Paulina

578 people in our graph share verified history with Paulina — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedPaulina: together at MIT (2009–2014)
Paulina: together at MIT
Paulina: together at Nuvig Therapeutics Inc.
Paulina: together at Zag Bio

About

Paulina Hill combines institutional VC and angel investing—writing $100K–$250K biotech checks to access scientific founders early; a PhD molecular biologist who actively architects complex therapeutics like targeted protein degraders.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Board director at Avilar Therapeutics

Intro paths

→

In turn, Paulina can intro founders to Avilar Therapeutics's investors below.

Avilar Therapeutics's investors · 5

Astellas Venture Management LLCSouth San Francisco · $200K – $5M checksMedical Excellence CapitalNew YorkOpenSky VenturesLos Angeles · since 2023RA CapitalBostonSanofi VenturesCambridge · $5M checks

Board director at NextPoint Therapeutics

Intro paths

→

In turn, Paulina can intro founders to NextPoint Therapeutics's investors below.

NextPoint Therapeutics's investors · 7

Catalio Capital ManagementNew York · since 2024Catalio Capital Management, LPNew YorkInvusNew York · since 2024Leaps by BayerLeverkusen · since 2024MPM BioImpactBoston · $1M – $15M checks · since 2024Sanofi VenturesCambridge · $5M checks · since 2024Sixty Degree CapitalNorth York · since 2024

Co-founders at NextPoint Therapeutics

GFGordon Freeman
Gordon FreemanScientific Founder
XZXingXing Zang
XingXing ZangScientific Founder

Experience

  1. Windward BioBoard Observercurrent2026 — present
  2. Diagonal TherapeuticsBoard Membercurrent2026 — present
  3. NormunityBoard Observercurrent2025 — present
  4. NormunityBoard Member2022 — 2025
  5. Odyssey TherapeuticsBoard Membercurrent2025 — present
  6. Attovia TherapeuticsBoard Observercurrent2025 — present
  7. Nuvig Therapeutics Inc.Board Membercurrent2024 — present
  8. Tisento TherapeuticsBoard Membercurrent2023 — present
  9. Zag BioBoard Observercurrent2023 — present
  10. Avilar TherapeuticsBoard Membercurrent2023 — present
  11. NextPoint Therapeutics, Inc.Board Membercurrent2023 — present
  12. SanofiPartner at Sanofi Venturescurrent2022 — presentCambridge, Massachusetts, United States
  13. Omega FundsPrincipal2019 — 2021Greater Boston
  14. Scorpion TherapeuticsBoard Observer2020 — 2021Boston, Massachusetts, United States
  15. IFM TherapeuticsBoard Member2019 — 2021
  16. Arrakis TherapeuticsBoard Observer2019 — 2021
  17. Polaris PartnersHealthcare Investment Team2012 — 2018Greater Boston
  18. MITResearch Affiliate in Langer Lab, Department of Chemical Engineering2012 — 2014
  19. Startup Leadership ProgramFellow and Co-Program Leader2011 — 2012
  20. MIT Langer LabPostdoctoral Research Fellow2009 — 2012
  21. MIT Postdoctoral AssociationFounding President2009 — 2012
  22. Siemens Venture CapitalMarket Analysis Intern2010 — 2011
  23. Wake Forest Institute for Regenerative MedicineTissue Engineering Pre-Doctoral Fellow2004 — 2009
  24. Office of Technology Asset Management, Wake Forest University Health SciencesTechnology Transfer Intern2008
  25. East Carolina University Brody School of MedicineUndergraduate Research Assistant2002 — 2004

Skills & more

Lifesciences14Biotechnology18Cell Culture13Molecular Biology11Biomaterials8Technology Transfer28Biochemistry48Biomedical Engineering8Nanotechnology4Drug Delivery8Chemistry13Protein Purification3
+9 moreEntrepreneurshipScienceTissue EngineeringHPLCStart-upsCellPatentsELISANeuroscience

Languages Polish

From Paulina's professional profile.

Colleagues at Sanofi Ventures

Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Christopher Gagliardi
Principal at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Kriti
Investor at Sanofi Ventures

Frequently asked questions

Who is Paulina Hill?
Paulina Hill combines institutional VC and angel investing—writing $100K–$250K biotech checks to access scientific founders early; a PhD molecular biologist who actively architects complex therapeutics like targeted protein degraders.
Where does Paulina Hill work?
Paulina Hill is Partner at Sanofi Ventures and Board director at Avilar Therapeutics and Board director at NextPoint Therapeutics.
What does Paulina Hill invest in?
Paulina Hill invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
Where did Paulina Hill go to school?
Paulina Hill studied at Massachusetts Institute of Technology (Postdoctoral Fellowship in Robert Langer's lab, Chemical Engineering); Wake Forest University School of Medicine (PhD, Molecular Medicine); East Carolina University (BS/BA, Quadruple major in Biochemistry).

Same school

Shared employers